CNTX-4975-05

DRUG4 trials

Sponsors

Centrexion Therapeutics

Conditions

Knee OsteoarthritisOsteoarthritis, Knee

Phase 1

A Study to Compare Levels of Capsaicin After Intra-Articular Injection and Topical Application in Patients With Painful Knee Osteoarthritis

CompletedNCT03576508

Centrexion TherapeuticsKnee Osteoarthritis

Start: 2018-06-25End: 2018-09-06Updated: 2018-11-14

Phase 3

A Phase 3 Efficacy and Safety Study of Intra-articular CNTX-4975-05 (Capsaicin) vs Placebo in Subjects With OA Knee Pain

CompletedNCT03429049

Centrexion TherapeuticsOsteoarthritis, Knee

Start: 2018-01-24End: 2019-11-22Updated: 2022-07-26

An Open-label, 8-week Safety, Efficacy, and Assessment of Cooling Methods for Administration of CNTX-4975-05 for Knee OA

CompletedNCT03661996

Centrexion TherapeuticsKnee Osteoarthritis

Start: 2018-09-18End: 2019-10-22Updated: 2022-03-09

A Clinical Study to Test Efficacy and Safety of Repeat Doses of CNTX-4975-05 in Patients With Osteoarthritis Knee Pain

CompletedNCT03660943

Centrexion TherapeuticsOsteoarthritis, Knee

Start: 2018-09-09End: 2020-06-11Updated: 2022-07-21

Related Papers

Clinical Benefit Of Cntx-4975 Intra-articular Injection For Moderate To Severe Osteoarthritis Knee Pain

Medicine & Science in Sports & Exercise2020-07-01